The complex nature of Sepsis makes it challenging to manage and mortality among Sepsis patients remains unacceptably high. The need for more effective strategies to help manage sepsis is urgent. Procalcitonin (PCT) is a critical piece of the puzzle. bioMérieux offers the novel biomarker, Procalcitonin, for bacterial infections and sepsis.
100 Rodolphe Street